Importance of local control in early-stage prostate cancer: Outcomes of patients with positive post-radiation therapy biopsy results treated in RTOG 9408

Daniel J. Krauss, Chen Hu, Jean Paul Bahary, Luis Souhami, Elizabeth M. Gore, Susan Maria Jacinta Chafe, Mark H. Leibenhaut, Samir Narayan, Javier Torres-Roca, Jeff Michalski, Kenneth L. Zeitzer, Viroon Donavanik, Howard Sandler, David G. McGowan, Christopher U. Jones, William U. Shipley

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose The purpose of this study was to assess the association between positive post-radiation therapy (RT) biopsy results and subsequent clinical outcomes in males with localized prostate cancer. Methods and Materials Radiation Therapy Oncology Group study 94-08 analyzed 1979 males with prostate cancer, stage T1b-T2b and prostate-specific antigen concentrations of ≤20 ng/dL, to investigate whether 4 months of total androgen suppression (TAS) added to RT improved survival compared to RT alone. Patients randomized to receive TAS received flutamide with luteinizing hormone releasing hormone (LHRH) agonist. According to protocol, patients without evidence of clinical recurrence or initiation of additional endocrine therapy underwent repeat prostate biopsy 2 years after RT completion. Statistical analysis was performed to evaluate the impact of positive post-RT biopsy results on clinical outcomes. Results A total of 831 patients underwent post-RT biopsy, 398 were treated with RT alone and 433 with RT plus TAS. Patients with positive post-RT biopsy results had higher rates of biochemical failure (hazard ratio [HR] = 1.7; 95% confidence interval [CI] = 1.3-2.1) and distant metastasis (HR = 2.4; 95% CI = 1.3-4.4) and inferior disease-specific survival (HR = 3.8; 95% CI = 1.9-7.5). Positive biopsy results remained predictive of such outcomes after correction for potential confounders such as Gleason score, tumor stage, and TAS administration. Prior TAS therapy did not prevent elevated risk of adverse outcome in the setting of post-RT positive biopsy results. Patients with Gleason score ≥7 with a positive biopsy result additionally had inferior overall survival compared to those with a negative biopsy result (HR = 1.56; 95% CI = 1.04-2.35). Conclusions Positive post-RT biopsy is associated with increased rates of distant metastases and inferior disease-specific survival in patients treated with definitive RT and was associated with inferior overall survival in patients with high-grade tumors.

Original languageEnglish (US)
Pages (from-to)863-873
Number of pages11
JournalInternational Journal of Radiation Oncology Biology Physics
Volume92
Issue number4
DOIs
StatePublished - Jul 15 2015

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Importance of local control in early-stage prostate cancer: Outcomes of patients with positive post-radiation therapy biopsy results treated in RTOG 9408'. Together they form a unique fingerprint.

Cite this